September 18, 2014 2:00 PM ET

Healthcare Equipment and Supplies

Company Overview of Miramar Labs, Inc.

Company Overview

Miramar Labs, Inc. operates as a medical device company. The company focuses on developing products for dermatologic medical conditions. Its products include miraDry System for the treatment of primary auxiliary (underarm) hyperhidrosis in adults; and miraWave technology, a technology platform using microwave energy for treatment in dermatologic conditions and other medical areas, such as oncology, cardiology, and urology. The company was formerly known as Foundry Newco X, Inc. Miramar Labs, Inc. was founded in 2006 and is based in Sunnyvale, California.

445 Indio Way

Sunnyvale, CA 94085

United States

Founded in 2006

Phone:

408-940-8700

Fax:

408-940-8795

Key Executives for Miramar Labs, Inc.

Chief Executive Officer
Age: 60
Co-Founder and Chairman of the Board
Chief Financial Officer and Senior Vice President
Age: 58
Vice President of Law and General Counsel
Managing Director for Asia Pacific Operations
Compensation as of Fiscal Year 2014.

Miramar Labs, Inc. Key Developments

Miramar Labs, Inc. Announces Management Changes

Miramar Labs, Inc. announced the appointment of R. Michael Kleine as its new president, chief executive officer and a member of its board of directors. Mr. Kleine will succeed Darrell Zoromski, the company's current president and CEO, who had previously announced his intent to step down in order to spend more time with his family. Prior to joining Miramar Labs, Mr. Kleine was most recently the CEO of EndoGastric Solutions (EGS) and will continue to serve as its Chairman of the Board. Mr. Zoromski played an active role in the CEO search and will continue to support the company in the coming months to ensure a smooth leadership transition.

Miramar Labs Announces CE Mark Approval for the miraDry(R) System to Treat Bothersome Underarm Sweat

Miramar Labs(R) Inc. announced that the miraDry(R) System received Conformite Europeenne (CE) Mark approval for the treatment of primary axillary hyperhidrosis, commonly known as bothersome underarm sweat. Clearance for miraDry was granted by the U.S. Food and Drug Administration in January 2011 following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics followed for 12 months post-treatment. A follow up study was conducted in Canada that showed patients experienced sustained improvement in sweat reduction and quality of life 24-months post treatment.

Miramar Labs Inc., Wins $1,500,000.00 Federal Contract

Miramar Labs Inc. announced that it has won a VA National Acquisition Center (Department of Veterans Affairs), Department of Veterans Affairs National Acquisition Center, has awarded a $1,500,000.00 modified federal contract on Nov. 15 for '65--Miramar Labs, Inc. 65IIA Medical Equipment & Supplies - V797D-40031 November 15, 2013 to November 14, 2018.

Similar Private Companies By Industry

Company Name Region
Philips Ultrasound, Inc. United States
Olympus Diagnostic Systems Group United States
Sensor Medical Technology, LLC United States
Voxys Healthcare Systems United States
Emerald Latex Gloves Company United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 16, 2013
--
Private Placement
December 6, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Miramar Labs, Inc., please visit miradry.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.